Air Ambulance Infectious Disease Unit

EAA works with both public and private institutions, providing governments, NGO’s and medical assistance companies with the ability to safely transport patients with conditions that might otherwise endanger the lives of crew and medical staff alike. Our EASA approved IsoPod allows the patient to be kept safe and comfortable for long range transport, without any risk of contact with the accompanying medical team. In this way EAA can provide a standard of MEDEVAC capability more commonly seen in military forces.

Providing this level of MEDEVAC within a civilian sphere follows EAA’s commitment to continue to improve and increase our range of services for clients and partners worldwide. The infectious dieses unit is another illustration of our ability to provide cutting edge aeromedical solutions, 24/7 and across the globe.

Originally designed for Ebola patients, the European Air Ambulance's Infectious Disease Unit now also serves Covid-19 patients. Developed in collaboration with air ambulance tech specialist AAT and decontamination equipment manufacturer VersarPPS, this unit aligns with European Air Ambulance protocols and is swiftly installable in Learjet 45XR air ambulances.

The unit features a lightweight, ergonomic modular tent system with EASA certification. Its flame-resistant PVC interior is tear-resistant and impermeable to biofluids. The tent, designed for single-patient transport, has a negative pressure enclosure ensuring no direct contact between the patient and the aircraft. Patients enter through a foldable airlock, ensuring safety and isolation.

Inside, patients can move freely with essential medical equipment, food, and drink at their disposal. Post-mission, all used equipment and waste are thoroughly disinfected and incinerated. The aircraft boasts an FFP3 filtration unit, adhering to CDC recommendations, and allows medical crew access via PVC sleeves, ensuring patient monitoring and care.

Dedicated crew members, trained for these missions, ensure readiness between 4 to 12 hours post-activation. The unit's efficacy was proven in March 2015 during a mission transporting a British national from Sierra Leone to the UK. This state-of-the-art Infectious Disease Unit underscores EAA's commitment to delivering top-tier aeromedical solutions globally.